Geneos Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29.6K | Sell |
|
|||||
|
2025
Q2 | $44.5K | Sell |
|
|||||
|
2025
Q1 | $68.6K | Buy |
|
|||||
|
2024
Q4 | $19.9K | Sell |
|
|||||
|
2024
Q3 | $1.95M | Buy |
|
|||||
|
2024
Q2 | $1.86M | Buy |
|
|||||
|
2024
Q1 | $2.07M | Buy |
|
|||||
|
2023
Q4 | $1.18M | Sell |
|
|||||
|
2023
Q3 | $985K | Buy |
|
|||||
|
2023
Q2 | $1.01M | Buy |
|
|||||
|
2023
Q1 | $867K | Buy |
|
|||||
|
2022
Q4 | $12.9K | Hold |
|
|||||
|
2022
Q3 | $11K | Hold |
|
|||||
|
2022
Q2 | $12K | Hold |
|
|||||
|
2022
Q1 | $16K | Hold |
|
|||||
|
2021
Q4 | $22K | Buy |
|
|||||
|
2021
Q3 | $1K | Hold |
|
|||||
|
2021
Q2 | $1K | Sell |
|
|||||
|
2021
Q1 | $232K | Buy |
|
|||||
|
2020
Q4 | $1K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1K | Sell |
|
|||||
|
2016
Q4 | $2K | Hold |
|
|||||
|
2016
Q3 | $2K | Buy |
|